Lopinavir/ritonavir: is early administration better in Covid-19?

Bhandari, Sudhir; Sharma, Shrikant; Gupta, Vishal; Bhargava, Abhishek; Rankawat, Govind; Roy, Durgesh.
Artículo | IMSEAR | ID: sea-212575

Documentos relacionados

  1. [Deafness after COVID-19? German version].
  2. [What is the effect of social distancing on the course of COVID-19 epidemic?]
  3. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
  4. ["Achieving closeness in video treatment despite distance"].
  5. [Air pollution: a determinant for COVID-19?]
  6. [Welche Behandlungsoptionen wurden von COVID-19-infizierten Yogaübenden als hilfreich empfunden? Ergebnisse einer Querschnittsanalyse].
  7. [Ethical principles compromised during the COVID-19 pandemic?]
  8. [Willingness to get vaccinated among hospital staff in Germany: What is the role of COVID-19 conspiracy assumptions?]
  9. [What are the differences between the various covid-19 vaccines?]
  10. [How hospitals, Intensive Care Units and nursing care of critically ill patients have changed during the Covid-19 outbreak? Results from an exploratory research in some European countries].